Beam Therapeutics, Inc. (BEAM)
28.46
-0.46
(-1.59%)
USD |
NASDAQ |
Feb 27, 16:00
28.40
-0.06
(-0.21%)
After-Hours: 20:00
Beam Therapeutics Cash from Investing (Quarterly) : 108.41M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -9.933M |
| Pacific Biosciences of California, Inc. | 26.03M |
| Intellia Therapeutics, Inc. | 27.53M |
| Stryker Corp. | -305.00M |
| Zimmer Biomet Holdings, Inc. | -322.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -83.29M |
| Cash from Financing (Quarterly) | 1.886M |
| Free Cash Flow | -360.05M |
| Free Cash Flow Per Share (Quarterly) | -0.8294 |
| Free Cash Flow to Equity (Quarterly) | -89.73M |
| Free Cash Flow to Firm (Quarterly) | -87.02M |
| Free Cash Flow Yield | -12.73% |